AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Cabotegravir in Nigeria
2 products registered with NAFDAC — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Apretude 30 mg Film Coated Tablets** Tablet | A4-100536 | GlaxoSmithKline Consumer Nigeria PLC (GSK) | active | 27 Sept 2028 |
| Apretude 600 mg Prolonged-release Suspension for Injection** Suspension for injection | A4-100537 | GlaxoSmithKline Consumer Nigeria PLC (GSK) | active | 27 Sept 2028 |
Cabotegravir — NAFDAC Registration Details
NAFDAC (Nigeria) has 2 registered products containing Cabotegravir, of which 2 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Cabotegravir registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.